(Q43477625)

23 November 2017

Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies (English)

1 reference

23 November 2017

Rieke J B Driessen

1

1 reference

23 November 2017

Jan B Boezeman

series ordinal

2

1 reference

23 November 2017

Peter C M Van De Kerkhof

series ordinal

3

1 reference

23 November 2017

Elke M G J De Jong

series ordinal

4

1 reference

23 November 2017

1 January 2009

1 reference

Journal of Dermatological Treatment

23 November 2017

1 reference

23 November 2017

20

1 reference

23 November 2017

1

1 reference

23 November 2017

42-47

1 reference

CLinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial.

23 November 2017

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

Relationship between smoking and the clinical severity of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

Frequent use of tobacco and alcohol in Chinese psoriasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

Psoriasis patients show signs of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

Psoriasis and occlusive vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

The risk of mortality in patients with psoriasis: results from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

Agreement between patient reports of cardiovascular disease and patient medical records

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

Smoking and the risk of psoriasis in women: Nurses' Health Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

Heart disease in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

The effect of weight on the efficacy of biologic therapy in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630802225702

10.1080/09546630802225702

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference